====== NFN1 1μM R03 exp100 ====== ==== Mechanism of Action ==== Nitrofuran derivative, candidate ALDH2 inhibitor * **Class / Subclass 1:** Infectious Disease / Antibiotic ==== Technical Notes ==== * **PubChem Name:** %%Ethyl 5-ethyl-2-[(5-nitrofuran-2-carbonyl)amino]thiophene-3-carboxylate%% * **Synonyms:** N/A * **CAS #:** 219620-36-7 * **PubChem CID:** [[https://pubchem.ncbi.nlm.nih.gov/compound/2799305|2799305]] * **IUPAC:** %%ethyl 5-ethyl-2-[(5-nitrofuran-2-carbonyl)amino]thiophene-3-carboxylate%% * **INCHI Name:** InChI=1S/C14H14N2O6S/c1-3-8-7-9(14(18)21-4-2)13(23-8)15-12(17)10-5-6-11(22-10)16(19)20/h5-7H,3-4H2,1-2H3,(H,15,17) * **INCHI Key:** OASNGLRREXBINI-UHFFFAOYSA-N * **Molecular Weight:** 338.34 * **Canonical SMILES:** CCC1=CC(=C(S1)NC(=O)C2=CC=C(O2)[N+](=O)[O-])C(=O)OCC * **Isomeric SMILES:** N/A * **Molecular Formula:** C14H14N2O6S {{:chemogenomics:structures:chem-0029.svg?nolink}} * **Supplier Name:** Maybridge * **Catalog #:** BTB05727SC * **Lot #:** N/A * **HRMS (ESI-TOF) m/z:** (M+H)+ Calcd for C14H14N2O6S 339.06453; found 339.0634 * **Platform ID:** NFN1 * **Min:** -1.7682; **Max:** 66.1639 {{:chemogenomics:dose_response:dr_100.png?nolink&500 |}} \\ \\ \\ \\ |< 300px 100px 200px >| ^ IC ^ Concentration (µM) ^ | IC10 |N/A | | IC20 |0.3734 | | IC30 |1.2393 | | IC40 |3.3135 | | IC50 |8.1701 | | IC60 |N/A | | IC70 |N/A | | IC80 |N/A | | IC90 |N/A | \\ ==== Screen Summary ==== * **Round**: 03 * **Dose**: 1µM * **Days of incubation**: 8 * **Doublings**: 6.9 * **Numbers of reads**: 10917491 ==== Screen Results ==== ^Sensitive/Resistant hits (FDR<0.05)^CRANKS^Score Plot^Top 30 Genes^Screen Similarity^Top 30 Sensitive GO terms^Top 30 Resistant GO terms^ |1/0|[[https://files.tyerslab.com/files/public/chemogenomics/cranks/NFN1_1uM_Round-3_exp100.txt|Scores]]|||||| {{:chemogenomics:cranks_plots:exp100.png?nolink}} ^Gene^CRANKS Score^FDR^ |[[:human_genes:G:GTPBP2|GTPBP2]]|-3.08|<0.01| |[[:human_genes:P:PUS7|PUS7]]|-2.76|0.12| |[[:human_genes:P:PRAMEF25|PRAMEF25]]|-2.72|0.60| |[[:human_genes:P:PRAMEF26|PRAMEF26]]|-2.70|0.61| |[[:human_genes:T:TCF4|TCF4]]|-2.45|0.23| |[[:human_genes:C:CCNC|CCNC]]|-2.40|0.23| |[[:human_genes:K:KDSR|KDSR]]|-2.33|0.23| |[[:human_genes:M:MCM9|MCM9]]|-2.32|0.23| |[[:human_genes:S:SLC12A2|SLC12A2]]|-2.30|0.23| |[[:human_genes:D:DNAJB11|DNAJB11]]|-2.29|0.23| |[[:human_genes:M:MNS1|MNS1]]|-2.28|0.51| |[[:human_genes:A:ASNSD1|ASNSD1]]|-2.28|0.23| |[[:human_genes:F:FLCN|FLCN]]|-2.25|0.23| |[[:human_genes:X:XPOT|XPOT]]|-2.24|0.23| |[[:human_genes:E:ERCC5|ERCC5]]|-2.23|0.23| |[[:human_genes:R:RTEL1|RTEL1]]|-2.18|0.23| |[[:human_genes:M:MAD2L2|MAD2L2]]|-2.14|0.23| |[[:human_genes:T:TRAPPC13|TRAPPC13]]|-2.12|0.23| |[[:human_genes:A:ACIN1|ACIN1]]|-2.10|0.37| |[[:human_genes:C:C1orf109|C1orf109]]|-2.09|0.37| |[[:human_genes:T:TSR3|TSR3]]|-2.07|0.29| |[[:human_genes:L:LMAN1L|LMAN1L]]|-2.05|0.39| |[[:human_genes:D:DPAGT1|DPAGT1]]|-2.04|0.59| |[[:human_genes:P:PRR21|PRR21]]|-2.01|0.37| |[[:human_genes:P:PUS3|PUS3]]|-2.00|0.37| |[[:human_genes:T:TMA16|TMA16]]|-1.99|0.47| |[[:human_genes:G:GPR107|GPR107]]|-1.99|0.37| |[[:human_genes:G:GCK|GCK]]|-1.98|0.51| |[[:human_genes:S:SCAI|SCAI]]|-1.98|0.37| |[[:human_genes:T:TNIP1|TNIP1]]|-1.94|0.39| |[[:human_genes:G:GAR1|GAR1]]|1.87|0.67| |[[:human_genes:A:ATAD2B|ATAD2B]]|1.89|0.67| |[[:human_genes:A:AGL|AGL]]|1.89|0.67| |[[:human_genes:N:NDC80|NDC80]]|1.90|0.76| |[[:human_genes:R:RAPSN|RAPSN]]|1.90|0.67| |[[:human_genes:K:KRTAP10-9|KRTAP10-9]]|1.91|0.67| |[[:human_genes:B:BTK|BTK]]|1.92|0.67| |[[:human_genes:O:OR5T2|OR5T2]]|1.94|0.67| |[[:human_genes:C:CCDC38|CCDC38]]|1.94|0.67| |[[:human_genes:A:ARF4|ARF4]]|1.96|0.67| |[[:human_genes:R:RPL8|RPL8]]|1.96|0.68| |[[:human_genes:C:CARF|CARF]]|1.98|0.67| |[[:human_genes:P:PRKCB|PRKCB]]|1.98|0.67| |[[:human_genes:I:ITPR1|ITPR1]]|2.00|0.67| |[[:human_genes:G:GART|GART]]|2.06|0.67| |[[:human_genes:C:CNOT2|CNOT2]]|2.06|0.67| |[[:human_genes:Z:ZXDB|ZXDB]]|2.06|0.67| |[[:human_genes:N:NCF4|NCF4]]|2.07|0.67| |[[:human_genes:T:TOP1MT|TOP1MT]]|2.12|0.67| |[[:human_genes:R:RNF4|RNF4]]|2.12|0.67| |[[:human_genes:C:CCDC71L|CCDC71L]]|2.15|0.67| |[[:human_genes:N:NHP2L1|NHP2L1]]|2.16|0.67| |[[:human_genes:C:CIB4|CIB4]]|2.17|0.67| |[[:human_genes:K:KPNB1|KPNB1]]|2.18|0.76| |[[:human_genes:N:NUS1|NUS1]]|2.20|0.67| |[[:human_genes:S:STK38|STK38]]|2.23|0.67| |[[:human_genes:H:HNRNPM|HNRNPM]]|2.26|0.67| |[[:human_genes:H:HSPA5|HSPA5]]|2.29|0.67| |[[:human_genes:Z:ZNF845|ZNF845]]|2.57|0.66| |[[:human_genes:C:COPB2|COPB2]]|2.65|0.67| ^Screen^Correlation^Plot^ |[[:results:exp389|PF-06409577 20μM R07 exp389]]|0.069|| |[[:results:exp249|Vinorelbine 0.001μM R05 exp249]]|0.051|| |[[:results:exp99|NFN1 0.4μM R03 exp99]]|0.052|| {{:chemogenomics:comparison_plots:exp100_vs_exp389.png?nolink |}} {{:chemogenomics:comparison_plots:exp100_vs_exp249.png?nolink |}} {{:chemogenomics:comparison_plots:exp100_vs_exp99.png?nolink |}} ^GO Term^Fold Change^Genes^ |pseudouridine synthesis|112.53|PUS7,TSR3,PUS3| No GO term hits below threshold. (FDR <0.05)